Hi RBx,
Good to hear from you, I am not concerned with raising funds at lower SP it only affects the largest SH in terms of dilution, if you have a billion shares and is able to sell your drug for $2 Billion than each share is worth $2 so you are still way in front from today's SP,. My concern is not being consistent with keeping the market informed as per previous trials communication.
Dr Kelly has been fantastic keeping SH informed, the reason is SP is undervalued is due to lack of information from management which breeds fear, uncertainty and lack of interest in the company.
I have great expectations going by previous trial results and the science, but am greatly disappointed with management so far.
IONIC may yet be a winner, page-5
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.005(4.76%) |
Mkt cap ! $32.14M | |||
| Open | High | Low | Value | Volume |
| 11.5¢ | 11.5¢ | 11.0¢ | $18.94K | 171.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 50000 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 12.5¢ | 66800 | 1 |
View Market Depth
| Last trade - 14.48pm 08/11/2024 (20 minute delay) ? |
| NOX (ASX) Chart |